HR 4063 · 114th Congress · Armed Forces and National Security
Jason Simcakoski PROMISE Act
Bill Progress
1
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.(2016-05-11)
Plain Language Summary
[AI summary unavailable — showing source text]
Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act or the Jason Simcakoski PROMISE Act This bill directs the Department of Veterans Affairs (VA) and the Department of Defense (DOD) to jointly update the VA/DOD Clinical Practice Guideline for Management of Opioid Therapy for Chronic Pain, including guidelines regarding: prescribing opioids for outpatient treatment of chronic, non-cancer pain; contraindications for opioid therapy; treatment of patients with post-traumatic stress disorder, psychiatric disorders, or a history of substance abuse or addiction; case management for patients transitioning between inpatient and outpatient health care and between DOD and non-DOD health care; routine and random urine drug tests to help prevent substance abuse; and options to augment opioid therapy with other clinical and complementary and integrative health services to minimize opioid dependence. The VA shall: expand the opioid safety initiative to include all VA medical facilities, including providing employees with pain management training, and establishment of pain management teams; track and monitor opioid use, including through the use of state program info…
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 4063, Promoting Responsible Opioid Management and Incorporating Scientific Expertise Act
May 5, 2016As ordered reported by the House Committee on Veterans’ Affairs on February 25, 2016
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office
Cosponsors (20)
9 Democrats11 Republicans